September 12, 2016 Leave a comment
A new study funded by the Avon Foundation for Women lays the groundwork for a better understanding of breast cancer diagnoses among Hispanics in the U.S.
The first-of-its-kind study, Breast Cancer among Hispanic Subgroups in the U.S., was conducted by the Sinai Urban Health Institute and released during the foundation’s biennial Breast Cancer Forum, held Sept. 7–9 in Miami. Furthering breast cancer research and access to quality care is one focus of the Avon Foundation for Women, alongside its efforts to reduce domestic and gender violence.
Drawing from multiple national data sources across multiple years, the new study explores breast cancer prevalence and mortality rates among Cuban, Mexican, Puerto Rican, and Central and South American women in the U.S. As a whole, Hispanics represent the largest racial/ethnic minority in the country, according to U.S. Census Bureau estimates. The American Cancer Society reports that breast cancer is the most commonly diagnosed cancer, and the leading cause of cancer deaths, in Hispanic women.
“As the company for women, Avon is committed to taking actions that matter most to women, and that is why the Avon Foundation is passionate about funding studies like this,” said Cheryl Heinonen, President of the Avon Foundation for Women. “We want to identify where the disparities lie so we can effectively shape and support programs that will have the greatest impact.”
The data shows that breast cancer mortality rates differ widely among the various groups that make up the Hispanic population. At the high end of the spectrum were Puerto Rican women (19.04 per 100,000 women) and Mexican women (18.78), while Central and South American women (10.15 per 100,000 women) were significantly less likely to die from breast cancer than other subgroups observed. According to Bijou Hunt of the Sinai Urban Health Institute, who authored the study, the findings have the potential to greatly improve individualization of care for Hispanic women diagnosed with the disease.